Loading interface...

ATORLIP F 5 mg TABLET

Manufactured byCipla Ltd.
ContainsAtorvastatin (5 mg) + Fenofibrate (145 mg)
Description
ATORLIP F 5 mg TABLET is a combination of Atorvastatin and Fenofibrate. It is used for the treatment of hyperlipidaemia (high levels of fats in the body). This medicine works by lowering the levels of bad cholesterol and increasing the levels of good cholesterol in your body. Thus, it prevents the risk of heart attack and stroke (a condition that causes reduced oxygen supply to the brain). ATORLIP F 5 mg TABLET show some side effects such as nausea, stomach pain, constipation, diarrhoea, flatulence, headache, muscle pain, etc. Inform your doctor if these side effects persist or worsen while taking the medication. ATORLIP F 5 mg TABLET is usually taken once a day, with or without food. Take the medicine at the same time each day for ease of remembering. Do not stop taking this medicine without consulting your doctor as it may worsen your condition. ATORLIP F 5 mg TABLET is not recommended for use if you are allergic to it. If you experience any allergic reaction such as skin rash, itching/swelling (especially of your face/tongue/throat), breathing difficulty, etc., contact your doctor immediately for further guidance. Avoid taking this medicine if you have severe kidney problems, pre-existing liver conditions, or gallbladder conditions such as gallstones (solid deposits that develop in your gallbladder). If you have diabetes, monitor your blood sugar levels regularly while taking this medicine as it can cause an alteration in blood sugar levels. ATORLIP F 5 mg TABLET is not recommended for use in children below 18 years of age. Consult your doctor if you are pregnant or are breastfeeding before taking this medicine.

Side effects

Major & minor side effects for ATORLIP F 5 mg TABLET

  • Nausea
  • Stomach pain
  • Muscle pain
  • Headache
  • Flatulence (Passing of gas)
  • Hyperglycemia
  • Increased liver enzyme levels in the blood
  • Skin rash and itching
  • Runny or stuffy nose
  • Constipation
  • Diarrhoea
  • Difficulty in breathing

Uses of ATORLIP F 5 mg TABLET

What is it prescribed for?

  • Hyperlipidaemia
  • Prevention of heart attack and stroke
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The time taken for ATORLIP F 5 mg TABLET to show its effect is not known.
  • How long do the effects of this medicine last?
    The time duration for which ATORLIP F 5 mg TABLET remains active in your body is not clinically established.
  • Is it safe to consume alcohol while taking this medicine?
    Consumption of alcohol is not recommended during treatment with ATORLIP F 5 mg TABLET due to the increased risk of liver damage and other side effects.
  • Is this a habit forming medicine?
    No habit-forming tendency has been reported for ATORLIP F 5 mg TABLET.
  • Can this medicine be taken during pregnancy?
    ATORLIP F 5 mg TABLET is not recommended for use during pregnancy as it may harm your developing foetus. Consult your doctor if you are pregnant.
  • Can this medicine be taken while breast-feeding?
    It is not known whether ATORLIP F 5 mg TABLET passes into the breastmilk. Hence is not recommended for use during breastfeeding unless necessary. Consult your doctor if you are breastfeeding.

Allergy

Avoid taking ATORLIP F 5 mg TABLET if you are allergic to it. Seek immediate medical attention if you notice any symptoms such as skin rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, breathing difficulty, etc.

Severe kidney impairment

ATORLIP F 5 mg TABLET is not recommended for use if you have severe kidney impairment as it may increase the risk of side effects and also worsen your condition. Hence consult your doctor before taking the medication.

Gallbladder disease

ATORLIP F 5 mg TABLET is not recommended for use if you have any condition affecting your gallbladder such as gallstones (solid deposits that develop in your gallbladder, a small pouch that stores bile produced by the liver). This medicine may further increase the risk of gallstones. Hence consult your doctor before taking the medication.

Liver impairment

ATORLIP F 5 mg TABLET may cause abnormal liver function, swelling of the liver, and liver damage. Hence, this medicine is not recommended for use if you have active liver problems as it may further worsen your condition.
Warnings for special population

Pregnancy

ATORLIP F 5 mg TABLET is not recommended for use during pregnancy as it may harm your developing foetus. Consult your doctor if you are pregnant.

Breast-feeding

It is not known whether ATORLIP F 5 mg TABLET passes into the breastmilk. Hence is not recommended for use during breastfeeding unless necessary. Consult your doctor if you are breastfeeding.
General warnings

Use in children

ATORLIP F 5 mg TABLET is not recommended for use in children below 18 years of age as the safety and efficacy data are not clinically established.

Haematologic changes

ATORLIP F 5 mg TABLET should be used with caution as it may cause a decrease in haemoglobin (an iron-containing protein responsible for carrying oxygen), haematocrit (blood test done to measure the proportion of red blood cells in the blood), and white blood cell levels.

Cognitive impairment

ATORLIP F 5 mg TABLET may cause memory loss, forgetfulness, confusion, etc. Hence, this medicine should be used with caution if you have cognitive impairment (a condition that causes a decline in mental abilities like memory, learning new things, focusing, or making decisions).

Missed Dose

Take the missed dose of ATORLIP F 5 mg TABLET as soon as you remember. If it is time for your next scheduled dose, skip the missed dose. Do not double your dose to make up for the missed one.

Overdose

Do not take excess dose than prescribed by your doctor. Contact your doctor if you suspect an overdose with ATORLIP F 5 mg TABLET.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

N/A

Instructions

Consumption of alcohol is not recommended during treatment with ATORLIP F 5 mg TABLET due to the increased risk of liver damage and other side effects.
Interaction with Medicine

Atazanavir

Clopidogrel

Cyclosporine

Clarithromycin

Disease interactions

Diabetes

Diabetes refers to high blood sugar levels. ATORLIP F 5 mg TABLET should be used with caution if you have diabetes as this medicine may alter the blood sugar levels. Therefore, regularly monitor your blood sugar levels while taking this medicine.

Rhabdomyolysis

Rhabdomyolysis is a condition that causes a breakdown of muscle tissue, leading to the release of muscle fiber contents into the blood. This may cause kidney damage and other problems. ATORLIP F 5 mg TABLET should be used with caution if you have rhabdomyolysis as it may worsen your condition.
Food interactions
Consumption of grapefruit juice is not recommended during treatment with ATORLIP F 5 mg TABLET as it may increase the absorption of this medicine into the blood. This may increase the risk of side effects.
Lab interactions
Information not available.
Take ATORLIP F 5 mg TABLET with or without food as instructed by your doctor. It is usually taken once a day. Do not break, chew, or crush the tablet. Take this medicine as advised by your doctor. Do not take in larger amounts than prescribed. Avoid taking ATORLIP F 5 mg TABLET with grapefruit juice as it may increase the risk of side effects. ATORLIP F 5 mg TABLET may increase your risk of muscle damage. Hence, consult your doctor if you experience unusual muscle pain or tenderness. Eat a healthy balanced diet and exercise regularly to get maximum benefits from the treatment.
Miscelleneous

Can be taken with or without food, as advised by your doctor

To be taken as instructed by doctor

Does not cause sleepiness

How it works
ATORLIP F 5 mg TABLET is a combination of Atorvastatin and Fenofibrate. Atorvastatin reduces the level of bad cholesterol in your blood. Fenofibrate works by decreasing the levels of bad cholesterol and triglycerides (fats) and increasing the levels of good cholesterol in the body.
Legal Status

Approved

Unknown

Unknown

Unknown

Classification

Category

HMG-CoA reductase inhibitors (statins), Fibric acid derivatives, Antihyperlipidemic combinations

Schedule

Schedule H

Drugs, H., 2022. Atorvastatin: MedlinePlus Drug Information. [online] Medlineplus.gov. Available at: [Accessed 27 July 2022].

https://medlineplus.gov/druginfo/meds/a600045.html

Drugs, H., 2022. Fenofibrate: MedlinePlus Drug Information. [online] Medlineplus.gov. Available at: [Accessed 27 July 2022].

https://medlineplus.gov/druginfo/meds/a601052.html

Accessdata.fda.gov. 2022. [online] Available at: [Accessed 27 July 2022].

https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020702s056lbl.pdf

Accessdata.fda.gov. 2022. [online] Available at: [Accessed 27 July 2022].

https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021656s029lbl.pdf
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 5 Aug 2022

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.